Patents by Inventor Geraldine Le Goff

Geraldine Le Goff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLOPENTENONES DERIVATIVES AND THEIR USE AS ANTIBIOTICS
    Publication number: 20240092716
    Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as a drug, especially as an antibiotic. The present invention also relates to a pharmaceutical composition comprising said compound of formula (I) and at least one pharmaceutically acceptable excipient. The present invention further concerns a method of preparation of a compound of formula (I?).
    Type: Application
    Filed: December 9, 2021
    Publication date: March 21, 2024
    Applicant: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Jamal-Eddine OUAZZANI CHAHDI, Géraldine LE GOFF, Jean-Félix DALLERY, Jean-François BETZER, Arnaud VOITURIEZ, Angela MARINETTI, Fanny CACHEUX
  • Compounds for treating neurodegenerative disorders
    Patent number: 11634452
    Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: April 25, 2023
    Assignees: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210087222
    Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 25, 2021
    Applicants: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210079035
    Abstract: Compounds for treating neurodegenerative disorders The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 18, 2021
    Applicants: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210070799
    Abstract: The invention relates to compounds of formula (I), their method of synthesis as well as their use to treat neurodegenerative disorders.
    Type: Application
    Filed: December 11, 2017
    Publication date: March 11, 2021
    Applicants: ETHNODYNE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Chérif Rabhi, Léon Cariel, Christian Da Costa Noble, Jamal Ouazzani, Guillaume Arcile, Géraldine Le Goff
  • 4-vinyl-2-cyclopenten-1-one derivatives, the production thereof, and the use of same as an antibiotic agent
    Patent number: 9751826
    Abstract: The invention relates to a compound of general formula (I) wherein: R1 is a hydrogen atom or a C1 to C4 alkyl radical; R2 is a C1 to C4 hydroxyl or alkoxyl radical; and R3 and R4 are independently a hydrogen atom or a C1 à C4 alkyl radical; and the enantiomers and mixtures of enantiomers thereof, especially in a racemic form.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: September 5, 2017
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Jamal Ouazzani, Emilie Adelin, Geraldine Le Goff
  • 4-VINYL-2-CYCLOPENTEN-1-ONE DERIVATIVES, THE PRODUCTION THEREOF, AND THE USE OF SAME AS AN ANTIBIOTIC AGENT
    Publication number: 20170121269
    Abstract: The invention relates to a compound of general formula (I) wherein: R1 is a hydrogen atom or a C1 to C4 alkyl radical; R2 is a C1 to C4 hydroxyl or alkoxyl radical; and R3 and R4 are independently a hydrogen atom or a C1 à C4 alkyl radical; and the enantiomers and mixtures of enantiomers thereof, especially in a racemic form.
    Type: Application
    Filed: May 6, 2015
    Publication date: May 4, 2017
    Applicant: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Jamal Ouazzani, Emilie Adelin, Geraldine Le Goff